A palm-sized plastic device turned by hand can report a person’s blood type and red-cell level in about one minute, with no electricity and no specialized training. Biomedical engineer Chien-Fu Chen and colleagues at National Taiwan University built it, and the work appeared in the journal Biosensors and Bioelectronics. Tests on 21 clinical samples matched hospital analyzers closely, though the group says field trials are still ahead.
The tech news worth your time: 400,000+ professionals from Google, Apple and OpenAI read Techpresso, a daily email with the most interesting tech news and insights.
We may earn a commission if you sign up.
The target is the moment after a disaster, a road crash or a battlefield injury, when responders need to know what blood a patient can safely receive and how much red-cell volume has been lost. Today both answers usually come from a laboratory, which means a sample has to travel, wait for a technician and wait again for a machine to run it, a chain that disaster conditions tend to break first. Chen said the aim was to move those two tests out of the lab and into the hands of first responders.
Centrifugal force, three antibodies and trapped clumps
As ScienceAlert described the paper, the user places a tiny drop of blood on the device and turns a crank. Centrifugal force drives the droplets through winding channels where they meet antibodies. The antibodies make matching blood cells clump together, and narrow slits catch the clumps.
Three antibodies sit in three separate channels, so the channel in which clumps pile up shows the blood type. That is the same agglutination reaction used in standard typing: red cells carry A or B antigens and clump when exposed to the antibody that recognizes them. Combining the four ABO groups with Rh positive or negative gives eight main types, and the device covers those eight.
Getting the group right is the point of the exercise. The same reference notes that a mismatched transfusion can cause a potentially fatal adverse reaction, and that such mismatches are rare in modern medicine because hospitals test before they transfuse. A device that moves that check to the roadside would be filling a gap that exists only when a laboratory is hours away.
The finished unit measures 180 millimeters by 60 millimeters by 50 millimeters, about 7 by 2.4 by 2 inches. The crank speed did not change accuracy, which matters for a tool meant to be operated by someone under stress.
Hematocrit from the same drop of blood
The amount of clumped material also tells the operator the hematocrit, the share of a blood sample’s volume made up of red cells. Typical values run around 45% for adult men and 40% for adult women, and a low reading can point to anemia or to bleeding. A responder who learns both the blood group and the hematocrit from one drop gets a rough read on what a patient needs and how urgently.
The idea builds on earlier work from the same lab. A 2023 paper in ACS Sensors from Chen’s group, describing a music-box-inspired centrifuge called the tFuge, showed that a constant-torque hand mechanism could measure hematocrit without electricity from no more than 10 microliters of fingerprick blood in under four minutes. The new device adds blood typing and shortens the wait.
The authors of that earlier study, catalogued in National Taiwan University’s research repository, were Liao, Chiu, Yuh Shiuan Chien and Chen. It reported that hematocrit tracked the length of the sedimented red-cell column in a tube almost linearly across a 10% to 60% range, with an R-squared of 0.99, so the group had a validated electricity-free hematocrit method before it added antibody channels.
21 samples, a 0.126% bias and what remains untested
The paper in Biosensors and Bioelectronics reports strong agreement with automated analyzers across 21 clinical samples. The mean bias in hematocrit was 0.126%, and the 95% limits of agreement ran from minus 0.63% to 0.88%. Put plainly, the device’s hematocrit readings sat on average about an eighth of a percentage point from the analyzer’s, and nearly all individual differences fell inside a band less than one and a half points wide. Those are narrow bands, but a sample of 21 is small, and nothing here substitutes for a larger trial run by outside teams.
The authors list their own limits. The assay covers the eight main blood types but not rarer ones, and the researchers write that future work will focus on extending it to additional blood group systems. It also does not yet work with unusually high or low hematocrit levels, which are the readings that signal the sickest patients. They conclude the platform shows strong potential as a practical diagnostic solution, a claim that still rests on field testing.
Chen’s remarks were reported by Phys.org in a separate write-up of the work. Neither report gives a price, a manufacturing partner or a regulatory path, so how soon a crank-and-read typer could reach an ambulance or a relief camp is unanswered. The immediate test is whether results hold when untrained people use it on fresh fingerprick samples outside a controlled lab.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
The tech news worth your time: Subscribe to Techpresso →
We may earn a commission if you sign up.
More from Morning Overview
- Regulators cleared the first U.S. small modular reactor, 4 months early
- Lake Powell sank to a record 3,517 feet, nearing the level that stops Glen Canyon Dam’s turbines
- Seven of Earth’s nine planetary boundaries are breached, and all seven are worsening
- The NSA says three phone features should be off whenever you aren’t using them
